Merrion Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
GIM
PCA
Merrion Investment Management's LLY Position: Q3 2026 in Review
Merrion Investment Management reduced its Eli Lilly (LLY) stake by 0.32% in Q3 2026, selling an estimated $5.9K and leaving 1,545 shares worth $1.79M. The position accounts for 0.89% of the portfolio, ranked #26.
Merrion Investment Management first reported a position in LLY in Q2 2021 and has held it in 22 quarters since. The position peaked at $1.86M in Q2 2026. 764 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Merrion Investment Management held 1,545 shares of Eli Lilly worth $1.79M as of Q3 2026.
- Merrion Investment Management sold 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
- Eli Lilly made up 0.89% of Merrion Investment Management's portfolio in Q3 2026, its #26 holding.
- Merrion Investment Management first reported a position in Eli Lilly in Q2 2021 and has held it in 22 quarters since.
- Merrion Investment Management's Eli Lilly position peaked at $1.86M in Q2 2026.
- 764 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Merrion Investment Management's 13F filing for Q3 2026, filed 16 Oct 2026.